NCT00974389View on ClinicalTrials.gov

S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery

PHASE2UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

June 30, 2010

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

bevacizumab

DRUG

tegafur-gimeracil-oteracil potassium

Trial Locations (1)

569-8686

RECRUITING

Osaka Medical College, Takatsuki

Sponsors
All Listed Sponsors
lead

Osaka Medical College

OTHER

NCT00974389 - S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery | Biotech Hunter | Biotech Hunter